B细胞淋巴瘤/白血病11A在正常和恶性血液形成中的作用
Haihang Zhang1, Junhao Zeng2, Fangling Zhang1
1Department of Hematology, the Second Xiangya Hospital, School of Life Sciences, Hunan Province Key Laboratory of Basic and Applied Hematology, Central South University, Changsha 410011, China.
Biology
|January 25, 2025
概括
B细胞淋巴瘤/白血病11A (BCL11A) 对于血液细胞发育至关重要,并与白血病有关. 向BCL11A为血液疾病和血液恶性瘤提供了潜在的基因疗法.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 基因规则 基因规则
背景情况:
- B细胞淋巴瘤/白血病11A (BCL11A) 是一个关键的转录因子.
- 它调节胎儿血红蛋白,影响遗传性血红蛋白病变.
- BCL11A还影响免疫细胞和红细胞的发育.
研究的目的:
- 审查BCL11A在正常和恶性血液形成中的作用.
- 详细介绍与BCL11A失调相关的血液学疾病.
- 探索目前针对BCL11A.A.的治疗策略.
主要方法:
- 对BCL11A在血液形成中的功能进行文献综述.
- 分析BCL11A在血液恶性瘤中的作用.
- 针对BCL11A.A的治疗方法的总结.
主要成果:
- BCL11A对造血细胞发育和免疫细胞功能至关重要.
- BCL11A失调有助于白血病和其他血液疾病.
- 准BCL11A显示出治疗血红蛋白病变和癌症的前景.
结论:
- BCL11A是正常和恶性血液形成中的关键调节剂.
- 了解BCL11A的功能对于开发新疗法至关重要.
- BCL11A代表了基因疗法和癌症治疗的重要目标.
相关概念视频
B Cell Activation and Differentiation
1.6K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.6K
Cells of the Adaptive Immune Response
944
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
944
Disorders of Leukocytes
843
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
843
Role of Hematopoietic Growth Factors
1.2K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.2K
Hematopoiesis
5.1K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.1K
Production of Formed Elements
1.3K
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Most HSCs commit to...
1.3K


